Breast Imaging Practice Questions

Q: "Linguine sign" and "Stepladder sign" that are specific for intracapsular breast implant rupture are both seen in:

MRI and USG respectively. ### Explanation The diagnosis of breast implant rupture is a high-yield topic in surgery, categorized into **intracapsular** (rupture of the envelope with silicone contained by the fibrous capsule) and **extracapsular** (silicone leakage into breast tissue). **1. Why Option C is Correct:** * **Linguine Sign (MRI):** This is the most sensitive and specific sign for intracapsular rupture on MRI (the gold standard imaging). It represents the collapsed, wavy elastomer shell of the implant floating within the silicone gel inside the fibrous capsule. * **Stepladder Sign (USG):** On ultrasound, an intracapsular rupture appears as multiple parallel linear or curvilinear echogenic lines within the implant. This is the sonographic equivalent of the Linguine sign. **2. Why Other Options are Incorrect:** * **Mammography (Options A, B, D):** Mammography is poor at detecting intracapsular ruptures because the radio-opaque silicone obscures the internal shell. It is better suited for detecting **extracapsular** rupture (visible as dense globules in the axilla or breast parenchyma). * **Sequence Mismatch:** The Linguine sign is strictly an MRI finding, while the Stepladder sign is strictly a USG finding. Options A, B, and D misattribute these signs to the wrong modalities. **3. Clinical Pearls for NEET-PG:** * **Gold Standard Imaging:** MRI is the most accurate investigation for implant rupture. * **Snowstorm Appearance:** This refers to extracapsular silicone leakage on Ultrasound, appearing as intense echogenic noise with posterior shadowing. * **Teardrop Sign:** An MRI finding indicating a "silent" or uncollapsed rupture where silicone is trapped between the shell and the capsule. * **Key Distinction:** Intracapsular rupture does not change the physical contour of the breast, whereas extracapsular rupture may present as a palpable lump or change in breast shape.

Q: Which of the following investigations is NOT indicated in a lactating woman presenting with painful breasts?

Computed Tomography (CT). ***Computed Tomography (CT)*** - **CT scan** is not a standard tool for breast imaging due to **high radiation doses** and poor soft-tissue resolution compared to other modalities. - It uses **ionizing radiation** which is unnecessary for evaluating breast pain in lactating women and is typically reserved only for **staging systemic disease**. *Ultrasound (USG)* - **First-line imaging** for lactating women with painful breasts to evaluate for **mastitis** or **breast abscess**. - **Safe** (no ionizing radiation), highly sensitive for detecting **fluid collections**, and not hindered by increased glandular density of lactating breast. *Mammography* - Can be indicated in lactating women when **malignancy is strongly suspected** despite reduced sensitivity. - Though **breast density** during lactation decreases mammographic sensitivity, it remains a valuable tool for specific clinical scenarios. *Magnetic Resonance Imaging (MRI)* - May be indicated for **problem-solving** in complex cases or when ultrasound findings are inconclusive. - Though **background parenchymal enhancement** during lactation can cause false positives, MRI has high sensitivity for breast pathology.

Q: What does BI-RADS 4 classification indicate for a breast lesion?

Suspicious of malignancy. **Explanation:** The **BI-RADS (Breast Imaging-Reporting and Data System)** is a standardized reporting tool developed by the American College of Radiology to communicate the risk of malignancy and guide clinical management. **1. Why "Suspicious of Malignancy" is Correct:** BI-RADS 4 is defined as a lesion that does not have the classic appearance of malignancy but has a sufficiently high level of suspicion to warrant a **tissue biopsy**. The risk of malignancy in this category ranges from **>2% to <95%**. It is further subdivided into: * **4A:** Low suspicion (2–10% risk) * **4B:** Moderate suspicion (10–50% risk) * **4C:** High suspicion (50–95% risk) **2. Analysis of Incorrect Options:** * **A. Benign (BI-RADS 2):** Indicates findings like a simple cyst or stable fibroadenoma. Risk of malignancy is 0%. * **B. Probably Benign (BI-RADS 3):** Indicates a <2% risk of malignancy. Management involves short-interval follow-up (usually 6 months) rather than immediate biopsy. * **D. Malignant (BI-RADS 5):** Indicates findings "highly suggestive of malignancy" with a risk of **≥95%**. BI-RADS 6 is used for biopsy-proven malignancy. **Clinical Pearls for NEET-PG:** * **BI-RADS 0:** Incomplete assessment; requires further imaging (e.g., additional views or ultrasound). * **Management Rule:** BI-RADS 1 & 2 require routine screening; BI-RADS 3 requires follow-up; BI-RADS 4 & 5 require tissue diagnosis (biopsy). * **Gold Standard:** While BI-RADS categorizes risk, the definitive diagnosis for any suspicious lesion remains histopathology.

Q: A 55-year-old post-menopausal woman, on hormone replacement therapy, presents with heaviness in both breasts. A screening mammogram reveals a high density speculated mass with a cluster of pleomorphic microcalcification and ipsilateral large axillary lymph nodes. The mass described here most likely represents?

Carcinoma. ### Explanation The clinical and radiological presentation strongly points toward **Breast Carcinoma**. **1. Why Carcinoma is correct:** The mammographic findings described are classic "red flags" for malignancy (BI-RADS 5): * **High-density spiculated mass:** Spiculation (radiating lines from the margin) is the most specific mammographic sign of breast cancer, representing desmoplastic reaction or infiltration into surrounding tissue. * **Pleomorphic microcalcifications:** Fine, irregular, and varying shapes/sizes of calcifications are highly suspicious for ductal carcinoma in situ (DCIS) or invasive cancer. * **Axillary Lymphadenopathy:** The presence of large ipsilateral nodes suggests lymphatic spread. * **Risk Factors:** Post-menopausal status and **Hormone Replacement Therapy (HRT)** are known risk factors for developing breast cancer. **2. Why other options are incorrect:** * **Fibroadenoma:** Typically presents as a well-circumscribed, oval, low-density mass with "popcorn" calcifications in older women. It is benign and does not cause spiculation or pleomorphic microcalcifications. * **Lymphoma:** Primary breast lymphoma is rare. It usually presents as a large, non-spiculated, circumscribed mass without microcalcifications. * **Cystosarcoma Phylloides:** These are large, rapidly growing, well-circumscribed fibroepithelial tumors. They rarely show microcalcifications or spiculation and typically spread hematogenously rather than to axillary nodes. **Clinical Pearls for NEET-PG:** * **Most common mammographic sign of malignancy:** A mass with spiculated margins. * **Most common type of breast cancer:** Invasive Ductal Carcinoma (NOS). * **BI-RADS Classification:** Remember that **BI-RADS 5** indicates a >95% probability of malignancy. * **HRT:** Long-term combined HRT (Estrogen + Progesterone) increases the risk of breast cancer and can increase breast density, making mammography harder to interpret.

Q: A 55-year-old post-menopausal woman, on hormone replacement therapy (HRT), presents with heaviness in both breasts. A screening mammogram reveals a high density speculated mass with a cluster of pleomorphic microcalcification and ipsilateral large axillary lymph nodes. The mass described here most likely represents?

Carcinoma. ### Explanation **1. Why Carcinoma is the Correct Answer:** The clinical and radiological features described are classic "red flags" for **Invasive Breast Carcinoma**. * **Demographics:** Post-menopausal status and the use of **Hormone Replacement Therapy (HRT)** are significant risk factors for breast cancer. * **Mammographic Findings:** A **high-density spiculated mass** is the most specific sign of malignancy (representing desmoplastic reaction). **Pleomorphic microcalcifications** (varying in size and shape) are highly suspicious (BI-RADS 4/5) for Ductal Carcinoma in Situ (DCIS) or invasive cancer. * **Lymphadenopathy:** The presence of large ipsilateral axillary lymph nodes strongly suggests metastatic spread. **2. Why Other Options are Incorrect:** * **Cystosarcoma Phylloides:** Typically presents as a large, rapidly growing, well-circumscribed, lobulated mass. It rarely shows microcalcifications or spiculated margins and usually spreads hematogenously rather than to axillary nodes. * **Lymphoma:** Primary breast lymphoma is rare. It usually appears as a large, non-calcified, circumscribed mass. While it involves lymph nodes, it lacks the spiculated margins and pleomorphic calcifications characteristic of epithelial carcinoma. * **Fibroadenoma:** These are benign tumors common in younger women. On mammography, they appear as well-defined "popcorn" calcifications (in involuting stages) or oval masses, not spiculated masses with pleomorphic calcifications. **3. Clinical Pearls for NEET-PG:** * **Most common mammographic sign of malignancy:** Spiculated mass. * **Most common type of breast cancer:** Invasive Ductal Carcinoma (NOS). * **BI-RADS Classification:** Pleomorphic and linear branching calcifications are high-probability markers for malignancy. * **HRT Risk:** Long-term combined HRT increases the risk of breast cancer and can increase breast density, making mammographic detection more challenging.

Q: What are the standard views for mammography?

Cranio-caudal and Medio-lateral oblique. **Explanation:** In screening mammography, the goal is to visualize the maximum amount of breast tissue with optimal compression. The standard "two-view" screening protocol consists of: 1. **Cranio-caudal (CC) View:** The X-ray beam passes from superior to inferior. This view is best for visualizing the **medial aspect** of the breast. 2. **Medio-lateral Oblique (MLO) View:** The X-ray beam passes from the superomedial to the inferolateral aspect (usually at a 30-60° angle). This is the most important view as it visualizes the **maximum amount of breast tissue**, including the **Upper Outer Quadrant (UOQ)** and the **Axillary Tail of Spence**, where most breast cancers occur. **Analysis of Incorrect Options:** * **AP and Lateral (A & B):** Anteroposterior (AP) views are not used in mammography because the breast must be compressed to reduce thickness and radiation dose; the CC view serves this purpose. * **Cranio-caudal and Medio-lateral (C):** While the Medio-lateral (ML) view exists, it is a **supplemental/diagnostic view** used to localize lesions (the "muffins rise, lead falls" rule) or perform biopsies. It does not capture the axillary tail as effectively as the MLO view. **High-Yield Clinical Pearls for NEET-PG:** * **BI-RADS:** The standard reporting system for mammography (0: Incomplete, 1: Normal, 2: Benign, 3: Probably Benign, 4: Suspicious, 5: Highly Suggestive of Malignancy, 6: Known Biopsy-proven Malignancy). * **Calcifications:** "Pleomorphic" or "Fine Linear Branching" calcifications are highly suspicious for DCIS/Malignancy. * **Screening Age:** Usually starts at 40 years (as per ACR guidelines). * **Younger Patients:** Ultrasound is the primary modality for women <30 years due to dense breast tissue and radiation sensitivity.

Q: What is the investigation performed?

Mammography. ***Mammography*** - The image shows **craniocaudal (CC)** and **mediolateral oblique (MLO) views** with **breast compression**, which are characteristic features of mammography. - Uses a **dedicated breast X-ray unit** with specialized **compression paddles** to spread breast tissue for optimal visualization of masses and calcifications. *MRI breast* - Requires **intravenous contrast** and produces **cross-sectional images** in multiple planes (axial, sagittal, coronal). - Shows **soft tissue contrast** and **enhancement patterns** rather than the compressed, flattened breast tissue seen in this image. *X-ray* - A **plain chest X-ray** would show the **thoracic cavity** including lungs, ribs, and mediastinum in a single projection. - Lacks the **specialized breast positioning** and **compression techniques** used in dedicated breast imaging. *Clinical examination* - Involves **physical palpation** and **visual inspection** of the breast without any imaging equipment. - Does not produce any **radiographic images** or require **radiation exposure** like the investigation shown.

Q: What is true about screening mammography?

Indicated in 50-60 years of age. ### **Explanation** **1. Why Option A is Correct:** Screening mammography is the gold standard for the early detection of breast cancer in asymptomatic women. While guidelines vary slightly (e.g., ACR, ACS, and WHO), the age group of **50–60 years** represents the peak window where screening has the highest sensitivity and significantly reduces mortality. In this age group, breast tissue becomes less dense (fatty replacement), making mammography highly effective at detecting microcalcifications and small masses. **2. Why Other Options are Incorrect:** * **Option B:** While mammography uses ionizing radiation, the dose is extremely low (approx. 0.4 mSv). The benefit of early cancer detection far outweighs the negligible theoretical risk of radiation-induced malignancy. * **Option C:** MRI is highly sensitive but has lower specificity (higher false positives) and is significantly more expensive. It is reserved for high-risk screening (e.g., BRCA mutations) or as an adjunct, not as a primary screening tool for the general population. * **Option D:** Ultrasound (USG) is the investigation of choice for women **<35 years** (dense breasts) and for differentiating cystic from solid lesions. However, it cannot reliably detect **microcalcifications**, which are the earliest sign of ductal carcinoma in situ (DCIS) seen on mammography. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Views:** Craniocaudal (CC) and Mediolateral Oblique (MLO). * **Earliest Sign of Malignancy:** Fine, pleomorphic, or linear branching **microcalcifications**. * **BI-RADS Classification:** A standardized reporting system (0: Incomplete; 1: Normal; 2: Benign; 3: Probably Benign; 4: Suspicious; 5: Highly Suggestive of Malignancy; 6: Known Biopsy-proven Malignancy). * **Tomosynthesis:** 3D mammography that reduces the effect of overlapping tissue.

Q: Diffuse increase in the parenchymal density of the breast is seen in which of the following conditions?

All of the above. **Explanation:** The mammographic density of the breast is determined by the ratio of radiopaque fibroglandular tissue to radiolucent adipose (fatty) tissue. A **diffuse increase in parenchymal density** occurs when there is either an increase in glandular elements or a significant loss of subcutaneous and retromammary fat. 1. **Hormone Replacement Therapy (HRT):** Estrogen and progesterone stimulate the proliferation of acinar and ductal structures. This leads to an increase in fibroglandular volume, making the breast appear more "dense" or "white" on a mammogram. This is a common pharmacological cause of increased density in postmenopausal women. 2. **Lipodystrophy:** This condition involves the abnormal distribution or loss of adipose tissue. Since fat provides the primary radiolucency in a mammogram, its loss results in a relative concentration of the remaining stromal and glandular elements, leading to increased parenchymal density. 3. **Cachexia:** In states of extreme malnutrition or systemic illness, the body mobilizes fat stores from the breast. The depletion of the fatty background causes the remaining parenchymal structures to appear more compact and dense. **High-Yield Clinical Pearls for NEET-PG:** * **BI-RADS Density Categories:** Breast density is classified from A (entirely fatty) to D (extremely dense). High density is a known independent risk factor for breast cancer and can mask small lesions (the "masking effect"). * **Other causes of diffuse density:** Pregnancy, lactation, and inflammatory breast cancer (due to edema/lymphatic obstruction). * **Weight Gain vs. Loss:** Weight gain typically increases fatty deposition (decreasing density), while weight loss increases apparent parenchymal density.

Q: What is the investigation of choice for high-risk breast cancer in a female?

MRI. **Explanation:** The investigation of choice for screening high-risk females for breast cancer is **Contrast-Enhanced MRI**. **1. Why MRI is the Correct Answer:** MRI has the highest sensitivity (approaching 90-100%) for detecting breast cancer compared to other modalities. In high-risk individuals—defined as those with a lifetime risk >20-25% (e.g., BRCA1/2 mutations, strong family history, or history of chest radiation)—MRI can detect small, invasive cancers that are often occult on mammography due to dense breast tissue typically found in younger high-risk patients. **2. Why Other Options are Incorrect:** * **Mammography:** While it is the gold standard for **average-risk** screening (starting at age 40), its sensitivity is lower in high-risk patients with dense breasts. In high-risk protocols, it is used as an adjunct to MRI, not as a standalone choice. * **USG (Ultrasound):** This is the investigation of choice for females **<30 years** presenting with a palpable lump or as an adjunct to characterize cysts. It is not a primary screening tool for high-risk patients. * **CT-PET:** This is used for staging advanced breast cancer or detecting distant metastasis; it has no role in primary screening due to high radiation and low resolution for microcalcifications. **High-Yield Clinical Pearls for NEET-PG:** * **Best initial investigation (Symptomatic >30 yrs):** Mammography. * **Best initial investigation (Symptomatic <30 yrs):** USG. * **Gold Standard for Implant Rupture:** MRI. * **BI-RADS Category 0:** Incomplete assessment, needs further imaging. * **Characteristic MRI finding of malignancy:** Rapid enhancement followed by rapid washout (Type III curve).

Question 1

"Linguine sign" and "Stepladder sign" that are specific for intracapsular breast implant rupture are both seen in:

Accepted Answer

MRI and USG respectively

Answer

Mammogram and USG respectively

Answer

MRI and Mammography respectively

Answer

Mammography and MRI respectively

Question 2

Which of the following investigations is NOT indicated in a lactating woman presenting with painful breasts?

Accepted Answer

Computed Tomography (CT)

Answer

Ultrasound (USG)

Answer

Mammography

Answer

Magnetic Resonance Imaging (MRI)

Question 3

What does BI-RADS 4 classification indicate for a breast lesion?

Accepted Answer

Suspicious of malignancy

Answer

Benign

Answer

Probably benign

Answer

Malignant

Question 4

A 55-year-old post-menopausal woman, on hormone replacement therapy, presents with heaviness in both breasts. A screening mammogram reveals a high density speculated mass with a cluster of pleomorphic microcalcification and ipsilateral large axillary lymph nodes. The mass described here most likely represents?

Accepted Answer

Carcinoma

Answer

Fibroadenoma

Answer

Lymphoma

Answer

Cystosarcoma phylloides

Question 5

A 55-year-old post-menopausal woman, on hormone replacement therapy (HRT), presents with heaviness in both breasts. A screening mammogram reveals a high density speculated mass with a cluster of pleomorphic microcalcification and ipsilateral large axillary lymph nodes. The mass described here most likely represents?

Accepted Answer

Carcinoma

Answer

Cystosarcoma phylloides

Answer

Lymphoma

Answer

Fibroadenoma

Question 6

What are the standard views for mammography?

Accepted Answer

Cranio-caudal and Medio-lateral oblique

Answer

AP and Lateral

Answer

AP and Medio-lateral oblique

Answer

Cranio-caudal and Medio-lateral view

Question 7

What is the investigation performed?

Accepted Answer

Mammography

Answer

MRI breast

Answer

X-ray

Answer

Clinical examination

Question 8

What is true about screening mammography?

Accepted Answer

Indicated in 50-60 years of age

Answer

Radiation due to mammography can cause carcinoma

Answer

MRI is better than mammography

Answer

USG is better than mammography

Question 9

Diffuse increase in the parenchymal density of the breast is seen in which of the following conditions?

Accepted Answer

All of the above

Answer

Hormone replacement therapy

Answer

Lipodystrophy

Answer

Cachexia

Question 10

What is the investigation of choice for high-risk breast cancer in a female?

Accepted Answer

MRI

Answer

CT-PET

Answer

Mammography

Answer

USG

Breast Imaging — MCQs

Breast Imaging — MCQs

On this page

Practice by Chapter

Want unlimited practice?